VCU Health Adult Outpatient Pavillion ( Site 0070), Richmond
Bon Secours St. Francis Medical Center-Oncology Research ( Site 0015), Midlothian · 11마일 거리

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06312176

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

피험자 모집 중3상

Research Site, Midlothian · 11마일 거리

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06103864

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

피험자 모집 중3상

Bon Secours Cancer Institute at St. Francis ( Site 0048), Midlothian · 11마일 거리

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06966700

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

피험자 모집 중3상

Clinical Trial Site, Midlothian · 11마일 거리

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07085767

Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab

피험자 모집 중

Adult Outpatient Pavilion, Richmond
Cellular Immunotherapies and Transplant Department, Richmond
VCU Health at Stony Point, Richmond

18세 이상 · 여성 · 2026. 9. 22. 업데이트됨 · NCT07426913

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

피험자 모집 중3상

Bon Secours Cancer Institute at St. Mary's, Richmond
Bon Secours Cancer Institute at Memorial Regional, Mechanicsville · 6마일 거리
Bon Secours St. Francis Medical Center, Midlothian · 11마일 거리

18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07173751

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

피험자 모집 중3상

Virginia Cancer Institute, Richmond

18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06492616

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

피험자 모집 중3상

Research Site, Midlothian · 11마일 거리

18세 ~ 130세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07647328

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

피험자 모집 중3상

Bon Secours Richmond Community Hospital, Richmond
Bon Secours Saint Mary's Hospital, Richmond
Bon Secours Cancer Institute at Reynolds Crossing, Richmond
외 4개

18세 ~ 60세 · 여성 · 2026. 9. 2. 업데이트됨 · NCT05879926

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

피험자 모집 중2/3상

Bon Secours St. Francis Medical Center, Midlothian · 11마일 거리

18세 이상 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT06926868

E-Mindfulness Approaches for Living After Breast Cancer

피험자 모집 중3상

Bon Secours Richmond Community Hospital, Richmond
Bon Secours Saint Mary's Hospital, Richmond
Virginia Cancer Institute, Richmond
외 4개

18세 ~ 50세 · 모든 성별 · 2026. 8. 4. 업데이트됨 · NCT06748222

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

피험자 모집 중

Virgina Community University Massey Comprehensive Cancer Center, Richmond

18세 ~ 99세 · 여성 · 2026. 7. 17. 업데이트됨 · NCT05592938

Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation

피험자 모집 중1상

Virginia Commonwealth University, Richmond

18세 이상 · 모든 성별 · 2026. 7. 14. 업데이트됨 · NCT06966388

Pre-Operative Window of ET to Inform RT Decisions (POWER II)

피험자 모집 중3상

Virginia Commonwealth University, Richmond

65세 이상 · 여성 · 2026. 6. 30. 업데이트됨 · NCT06507618

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

피험자 모집 중3상

Bon Secours St. Francis Medical Oncology Center, Midlothian · 11마일 거리

18세 이상 · 모든 성별 · 2026. 5. 18. 업데이트됨 · NCT06757634

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

피험자 모집 중3상

Bon Secours Cancer Institute at Memorial Regional Medical Center, Mechanicsville · 6마일 거리

18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT07062965

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

피험자 모집 중3상

Bon Secours Saint Mary's Hospital, Richmond
Bon Secours Cancer Institute at Reynolds Crossing, Richmond
Bon Secours Memorial Regional Medical Center, Mechanicsville · 6마일 거리
외 1개

50세 ~ 70세 · 모든 성별 · 2026. 4. 23. 업데이트됨 · NCT04852887

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

피험자 모집 중관찰 연구

VCU Massey Cancer Center at Stony Point, Richmond
Virginia Commonwealth University/Massey Cancer Center, Richmond

18세 이상 · 모든 성별 · 2026. 3. 17. 업데이트됨 · NCT06418204

PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients

피험자 모집 중관찰 연구

VCU Massey Comprehensive Cancer Center, Richmond

18세 이상 · 모든 성별 · 2026. 3. 16. 업데이트됨 · NCT06610539

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

피험자 모집 중관찰 연구

VCU Massey Comprehensive Cancer Center, Richmond
Bon Secours Cancer Institute at St. Francis, Midlothian · 11마일 거리

18세 이상 · 모든 성별 · 2026. 1. 20. 업데이트됨 · NCT06401421

ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy

피험자 모집 중2상

Virginia Commonwealth University, Richmond

45세 ~ 79세 · 여성 · 2025. 11. 21. 업데이트됨 · NCT06185205

CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

피험자 모집 중건강한 지원자 환영

Virginia Commonwealth University, Richmond

18세 이상 · 여성 · 2025. 8. 28. 업데이트됨 · NCT05130606

다른 도시의 유방암 시험

Richmond의 다른 연구

ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.